(lp0
S'Ampio Pharmaceuticals Amends Warrant Agreement PR Newswire  - 18 hours ago ENGLEWOOD, Colo., March 28, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, announced that it&nbsp;...AMPIO PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... - Market Exclusive'
p1
aS'Ampio Pharmaceuticals Provides Corporate Update Yahoo Finance - Mar 20, 2017 ENGLEWOOD, Colo., March 20, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, announced an&nbsp;...Investors Spotlight: Ampio Pharmaceuticals, Inc.  - Is storiesAmpio Pharmaceuticals, Inc.  in-depth technical analysis - Post Analyst'
p2
aS'Ampio Pharmaceuticals - Running On Fumes Seeking Alpha - Feb 1, 2017 My interest in Ampio Pharmaceuticals Inc.,  was established several days ago during the Optometric Leaders Forum in Montreal, Canada.'
p3
aS'Update - Ampio Pharmaceuticals Provides Corporate Update Yahoo Finance - Mar 22, 2017 ENGLEWOOD, Colo., March 22, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, today announced&nbsp;...Ampio Pharma  Announces Issuance of China Patent - StreetInsider.comAmpio Updates Intellectual Property and Regulatory Exclusivity Strategy to ... - PR Newswire '
p4
aS'Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA ... PR Newswire  - Oct 14, 2015 ENGLEWOOD, Colo., Oct. 14, 2015 /PRNewswire/ - Ampio Pharmaceuticals, Inc.  today announced that Ampio met with the Division of the Transplant and Ophthalmology Products of the FDA to discuss the results of the OptimEyes&nbsp;...'
p5
aS'Ampio Pharmaceuticals Inc. AMPE  Wall Street Journal - May 20, 2011 Ampio Pharmaceuticals Inc. AMPE . search. View All companies. AT CLOSE 4:02 PM EST 03/10/17. $0.80 USD; 0.00 -0.12%.'
p6
aS'Ampio Pharmaceuticals Inc.  Plunges 5.11% on March 21 Equities.com - Mar 21, 2017 Ampio Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.11%, or a loss of $-0.0437 per share, to close at $0.81.'
p7
aS'Ampio Pharmaceuticals  Stock Tanks Today after Treatment Fails To Reach ... TheStreet.com - Apr 20, 2015 NEW YORK  -- Ampio Pharmaceuticals  shares are down 65.76% to $2.71 in trading on Monday after the biopharmaceutical company announced that the multiple injection STRIDE study for pain reliever Ampion did not reach its primary&nbsp;...AMPIO Announces Ampion STRIDE Study Results - PR Newswire '
p8
aS'Ampio Pharmaceuticals Inc.  Plunges 5.48% on March 08 Equities.com - Mar 8, 2017 Ampio Pharmaceuticals Inc.  had a rough trading day for Wednesday March 08 as shares tumbled 5.48%, or a loss of $-0.0452 per share, to close at $0.78.Would You Buy Ampio Pharmaceuticals, Inc.  On These Analyst Ratings? - Fiscal Standard'
p9
aS'Sell Your Ampio Pharmaceuticals Shares Now: AMPE Is Setting Up For A Secondary Seeking Alpha  - Jan 27, 2015 Two of the four executives at Ampio have direct ties to Isolagen, an aesthetic procedure company that was accused by shareholders of malfeasance and ultimately went bankrupt.'
p10
a.